Table 3.
Children and adolescents MDD | Adults MDD | ||
---|---|---|---|
Pathways | p-value | Pathways | p-value |
IPA analyses | |||
Adenine and Adenosine Salvage III | 6.56E-07 | tRNA Charging | 2.80E-04 |
Purine Ribonucleosides Degradation to Ribose-1-phosphate | 1.10E-06 | FXR/RXR Activation | 7.80E-04 |
Adenosine Nucleotides Degradation II | 3.14E-06 | S-adenosyl-L-methionine Biosynthesis | 2.52E-03 |
Purine Nucleotides Degradation II (Aerobic) | 7.40E-06 | Methionine Salvage II (Mammalian) | 2.84E-03 |
Glycine Degradation (Creatine Biosynthesis) | 3.69E-05 | Lipoate Biosynthesis and Incorporation II | 3.15E-03 |
MetaboAnalyst analyses | |||
Fatty acid biosynthesis | 9.03E-5 | Glycerophospholipid metabolism | 7.83E-4 |
Arginine and proline metabolism | 3.93E-02 |
IPA ingenuity pathway analysis, MDD major depressive disorder